MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC

June 25, 2026 8:15 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel therapies for neurologic, neuropsychiatric, and metabolic disorders, today announced new preclinical pharmacology data on Mira-55, the Company's cannabinoid analog in development for chronic inflammatory pain. Mira-55 is designed to act on the same cannabinoid receptors as compounds found in cannabis, including THC. A...

Read more

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

June 25, 2026 8:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Anastrozole tablets of 1mg for the Canadian market. Anastrozole is the generic equivalent of the brand name breast cancer drug, Arimidex®.Anastrozole is a highly prescribed non-steroidal aromatase inhibitor. It works by lowering estrogen levels...

Read more

Moderna Science Day Highlights Expanding Potential of mRNA Platform

June 25, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced research and early development updates at its Science Day event."As we execute our strategic plan to become a diversified, multi-modality biotechnology company, we are preparing to manage three commercial franchises, Infectious Disease Vaccines, Intismeran, and Rare Disease Therapeutics, while advancing a broad mRNA pipeline and continuing to invest in research and development," said Stéphane Bancel,...

Read more

Zomedica's Assisi Loop(R) Products Designated "Fear Free(R)" as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC

June 25, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the renewal of the alliance between the Assisi® brand and Fear Free, the initiative dedicated to preventing and alleviating fear, anxiety, and stress (FAS) in pets.The renewed agreement reinforces a shared commitment to improving the emotional...

Read more

Dr. Wallace Brucker Pioneers Executive Concierge Medicine in Las Vegas, Marking the Next Evolution of Workplace Wellness

June 25, 2026 1:20 AM

As corporate wellness programs evolve beyond annual physicals and generic health screenings, a new model is emerging that treats executive health as strategic infrastructure rather than routine maintenance. Dr. Wallace Brucker, a pioneer and leader in executive concierge medicine, is at the forefront of this transformation in Las Vegas, offering comprehensive performance optimization through LV Longevity Lab. Executive concierge medicine...

Read more

JellyFil Releases 2026 Supplement Facts Including Full Ingredients Breakdown, Package Pricing, and Money-Back Guarantee Terms

June 25, 2026 1:15 AM

JellyFil, a dietary supplement distributed across the United States by Instituto Experience of Lakeland, Florida, has released updated product information for its gummy dietary supplement. The 2026 update covers the product's current ingredient formulation, recommended use guidelines, available package sizes and pricing, refund and return procedures, and customer service contact details. JellyFil is making this information publicly available...

Read more

The DEA Marijuana Hearing Starts June 29. the Real Rescheduling Fight is Already in the D.C. Circuit.

June 24, 2026 5:15 PM

As the Drug Enforcement Administration prepares to convene its long-awaited marijuana rescheduling hearing on June 29, much of the cannabis industry is focused on what will happen inside the hearing room.MMJ International Holdings believes the more important question is what happens after the hearing ends. Because regardless of who testifies, regardless of what evidence is introduced, and regardless of what recommendations emerge from the...

Read more

Xcelerate Announces Progress on Medical Deployment Program in Africa

June 24, 2026 9:25 AM

Management of Xcelerate, Inc. (OTC PINK:XCRT) today announced that it is making continued progress with its two principal business objectives, including its AfiyaSasa Africa ("ASA") healthcare program and its intellectual property/patent portfolio. Management believes this progress builds on the Company's previously announced strategic focus on healthcare technology deployment and commercialization initiatives in Africa.ASA Africa Program...

Read more

Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes Major Corporate Overhaul with Launch of Three Advanced Websites and In-House Software Platforms

June 24, 2026 9:17 AM

Medical Care Technologies, Inc. (OTC PINK:MDCE) today announced the successful launch of its newly revamped corporate websites and upgraded digital platforms for its subsidiaries, marking a significant leap forward in operational efficiency, cost savings, and customer accessibility.The new corporate website at www.medicalcaretechnologies.com now offers new Vision API services and comprehensive web software development solutions, expanding the...

Read more

Navix Health and Cuepri Launch Branded Alumni Apps That Turn Discharge Into the Start of the Relationship, Not the End

June 24, 2026 9:00 AM

Navix Health, the AI-native EMR, CRM, and RCM platform built exclusively for behavioral health treatment facilities, today announced a partnership with Cuepri, the AI-native care experience platform for behavioral health. Through the partnership, any Navix facility can launch its own branded client and alumni app, in its own name and colors, with no build project, no setup fee, and nothing to maintain.The Alumni GapMost facilities know that what...

Read more

Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs

June 24, 2026 8:30 AM

Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC today announced the nationwide Amazon launch of its innovative BUZZ BOMB™ 50mg caffeine stick packs. This e-commerce expansion represents a significant milestone in BUZZ BOMB™'s mission to provide clean, accessible energy to athletes, professionals, fitness enthusiasts, and busy individuals. By launching on the U.S....

Read more

Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion

June 24, 2026 8:17 AM

Modular Medical, Inc. (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery technology, today announced that the Pivot™ tubeless insulin patch pump is now commercially available. This marks the start of real-world patient use, and the Company's transition to a commercial-stage medical device company.As only the second fully electronic, tubeless insulin pump available in the United States, Pivot is designed to make pump therapy...

Read more

AMIA Names Thomas Kannampallil, PhD, FACMI, FAMIA, as Next Editor-in-Chief of JAMIA

June 24, 2026 8:00 AM

The American Medical Informatics Association (AMIA) has named Thomas Kannampallil, PhD, FACMI, FAMIA, as the next Editor-in-Chief of the Journal of the American Medical Informatics Association (JAMIA), AMIA's flagship peer-reviewed journal. The appointment, made by the AMIA Board of Directors, is effective January 1, 2027.Dr. Kannampallil will succeed Suzanne R. Bakken, PhD, RN, FAAN, FACMI, who has served as JAMIA's Editor-in-Chief since...

Read more

As Consumers Get Smarter About Supplements, Nutriessential Sets the Benchmark

June 24, 2026 8:00 AM

Nutriessential, a US-based dietary supplement provider, has spent nearly two decades refining its business model that prioritises providing evidence-based dietary supplements to global customers for scientific accountability and implementing a drop-shipping model to ensure biochemical integrity and potency preservation. The company is bypassing recent business trends where speed, pricing, and volume often dictate business decisions. Quality and...

Read more

AQP One Introduces BioBaseline(TM) as a Foundational Standard for Physiological Intelligence

June 24, 2026 3:00 AM

AQP One, Inc., a U.S.-based health technology company, today announced the formal introduction of BioBaseline™, a proprietary physiological modeling framework designed to serve as a foundational standard within its expanding JBA AICare™ Physiological Intelligence Platform.The announcement follows the company's recent expansion of JBA AICare™ into metabolic and GLP-1 trend intelligence, and marks the next step in AQP One's strategy to build an...

Read more

Andes Health Mart Pharmacy Honored as IPC's 2026 Most Valuable Pharmacy

June 24, 2026 1:00 AM

Independent Pharmacy Cooperative (IPC) is proud to announce Andes Health Mart Pharmacy of Effingham, IL, as the recipient of the Dan Moudry Most Valuable Pharmacy (MVP) Award for 2026. The prestigious award was presented to Chip Andes at the IPC Annual Business Meeting on June 19, during McKesson ideaShare 2026 in Denver, CO.Chip Andes has spent decades building Andy's Health Mart Pharmacy into a cornerstone of care in his community, navigating...

Read more

AI medical conference returns to Miami July 10-12

June 23, 2026 9:25 PM

For more than seven years, Boss Doctors has championed physician leadership in healthcare technology, entrepreneurship, and industry transformation. The annual conference serves as a platform where healthcare professionals gain practical strategies for expanding their influence and creating opportunities beyond clinical practice.This year's theme, "Educate, Innovate, and Invest with AI", highlights the organization's mission to equip physicians...

Read more

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010

June 23, 2026 6:00 PM

Onco-Innovations Limited (NEO:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into a services agreement with Nanosoft Polymers ("Nanosoft"), a specialized polymer engineering and drug delivery company, to support the continued development of ONC010, the Company's lead nanoparticle-formulated Polynucleotide Kinase Phosphatase ("PNKP") inhibitor.Under the agreement, Nanosoft will...

Read more

BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption

June 23, 2026 5:20 PM

BioNxt Solutions Inc. (CSNX:BNXT)(OTCQB:BNXTF)(FSE:BXT) (the "Company" or "BioNxt") is pleased to announce that it has closed its previously announced non-brokered private placement (the "LIFEOffering") of units of the Company ("Units") pursuant to the Listed Issuer Financing exemption available under Part 5A of National Instrument 45-106 - Prospectus Exemptions. Pursuant to the LIFE Offering, the Company issued an aggregate of 6,060,606 Units...

Read more

Desert Oasis Healthcare Home Health Clinical Manager Honored with Prestigious Home Health Leadership Award

June 23, 2026 12:40 PM

Desert Oasis Healthcare (DOHC) is proud to announce that Candice Longshore, RN, Clinical Manager for Desert Oasis Healthcare Home Health, has been selected as the recipient of the Lillian H. O'Brien Supervisor Home Health Award, recognizing her outstanding leadership, clinical excellence, and unwavering commitment to compassionate patient care. The award will be presented during a special ceremony on June 23, 2026, at The Westin Rancho Mirage...

Read more